Zimmer Biomet’s reason was because of “the more complex and lengthier path with the US Food and Drug Administration (FDA) than initially expected,” Bactiguard said in a news release. The companies have been in partnership for orthopedic products since 2022.
The partnership will remain intact for Zimmer Biomet’s trauma product segment, which was signed in 2019.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
